ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia

被引:27
|
作者
Menezes, J. [1 ]
Salgado, R. N. [1 ]
Acquadro, F. [1 ]
Gomez-Lopez, G. [2 ]
Carralero, M. C. [1 ]
Barroso, A. [3 ]
Mercadillo, F. [4 ]
Espinosa-Hevia, L. [1 ]
Talavera-Casanas, J. G. [5 ]
Pisano, D. G. [2 ]
Alvarez, S. [1 ]
Cigudosa, J. C. [1 ]
机构
[1] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Mol Cytogenet Grp, Madrid, Spain
[2] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomput Program, Bioinformat Unit, Madrid, Spain
[3] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genet Grp, Madrid, Spain
[4] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Clin Familial Canc Unit, Madrid, Spain
[5] Ntra Sra de Candelaria Hosp, Hematol & Hemotherapy Serv, Santa Cruz De Tenerife, Spain
来源
BLOOD CANCER JOURNAL | 2013年 / 3卷
关键词
SOMATIC MUTATIONS; NPM1;
D O I
10.1038/bcj.2013.54
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:e157 / e157
页数:3
相关论文
共 50 条
  • [31] Mutations of TET2, IDH1, IDH2 and ASXL1 In Chronic Myeloid Leukemia
    Roche-Lestienne, Catherine
    Alice, Marceau
    Labis, Elise
    Nibourel, Olivier
    Coiteux, Valerie
    Guilhot, Joelle
    Legros, Laurence
    Nicolini, Franck
    Rousselot, Philippe
    Gardembas, Martine
    Helevaut, Nathalie
    Frimat, Cecile
    Guilhot, Francois
    Preudhomme, Claude
    BLOOD, 2010, 116 (21) : 1382 - 1382
  • [32] Bilineal T lymphoblastic and myeloid blast transformation in chronic myeloid leukemia with TP53 mutation-an uncommon presentation in adults
    Krishnan, S.
    Sabai, K.
    Chuah, C.
    Tan, S. Y.
    CURRENT ONCOLOGY, 2014, 21 (01) : E147 - E150
  • [33] Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
    Kim, Hyun-Young
    Lee, Ki-O
    Park, Silvia
    Jang, Jun Ho
    Jung, Chul Won
    Kim, Sun-Hee
    Kim, Hee-Jin
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (06) : 495 - +
  • [34] Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia
    Bomben, Riccardo
    Rossi, Maria Francesca
    D'Agaro, Tiziana
    Bittolo, Tamara
    Zucchetto, Antonella
    Tissino, Erika
    Pozzo, Federico
    Vit, Filippo
    Bulian, Pietro
    Degan, Massimo
    Zaina, Eva
    Cattarossi, Ilaria
    Nanni, Paola
    Chivilo, Hillarj
    D'Arena, Giovanni Francesco
    Chiarenza, Annalisa
    Santinelli, Enrico
    Zaja, Francesco
    Pozzato, Gabriele
    Di Raimondo, Francesco
    Del Poeta, Giovanni
    Gattei, Valter
    BLOOD, 2018, 132
  • [35] Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations
    Hwang, Steven R.
    Wang, Yucai
    Rabe, Kari G.
    He, Rong
    Kenderian, Saad S.
    Muchtar, Eli
    Hampel, Paul J.
    Kay, Neil E.
    Call, Timothy G.
    Koehler, Amber
    Behnken, Amy L.
    Leis, Jose F.
    Braggio, Esteban
    Shi, Min
    Viswanatha, David S.
    Van Dyke, Daniel L.
    Slager, Susan L.
    Parikh, Sameer A.
    Ding, Wei
    BLOOD, 2022, 140 : 12390 - 12392
  • [36] TP53 MUTATIONS ARE INFREQUENT IN NEWLY-DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA
    Murray, F.
    Zainuddin, N.
    Kanduri, M.
    Gunnarsson, R.
    Smedby, K. Ekstrom
    Enblad, G.
    Jurlander, I.
    Juliusson, G.
    Rosenquist, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 39 - 39
  • [37] COMPARISON TP53 MUTATION SITES IN BLAST PHASE OF MYELOPROLIFERATIVE NEOPLASM AND ACUTE MYELOID LEUKEMIA
    Chen, Dong
    Cantu, Miguel
    Siddon, Alexa
    Weinberg, Olga
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 : 24 - 24
  • [38] Allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia with ASXL1-, RUNX1- and TP53 mutations
    Egger-Heidrich, K.
    Middeke, J. M.
    Schaefer-Eckart, K.
    Kaufmann, M.
    Einsele, H.
    Mueller-Tidow, C.
    Roesler, W.
    Haenel, M.
    Baldus, C. D.
    Fransecky, L.
    Stoelzel, F.
    Roellig, C.
    Taube, F.
    Kramer, M.
    Stasik, S.
    Neubauer, A.
    Burchert, A.
    Berdel, W. E.
    Stelljes, M.
    Bug, G.
    Ehninger, G.
    Bornhaeuser, M.
    Thiede, C.
    Schetelig, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 50 - 50
  • [39] TP53 Codon 72 polymorphism and risk of chronic myeloid leukemia Research Article
    Sailaja, K.
    Surekha, D.
    Rao, D. Nageswara
    Rao, D. Raghunadha
    Balakrishna, B.
    Vishnupriya, S.
    GENE THERAPY AND MOLECULAR BIOLOGY, 2009, 13B : 316 - 320
  • [40] Clonal evolution and prognostic impact of mutations in blast crisis of chronic myeloid leukemia
    Ochi, Yotaro
    Yoshida, Kenichi
    Nannya, Yasuhito
    Sasaki, Hikaru
    Mitani, Kinuko
    Hosoya, Noriko
    Ishikawa, Takayuki
    Ohyashiki, Kazuma
    Takahashi, Naoto
    Shiozawa, Yusuke
    Makishima, Hideki
    Shiraishi, Yuichi
    Sanada, Masashi
    Takaori, Akifumi
    Miyano, Satoru
    Ogawa, Seishi
    CANCER SCIENCE, 2022, 113 : 1271 - 1271